Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001688192-25-000004

Director bought 20,000 shares at $57.03 ($1,140,600)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Treco Douglas A Director 2025-08-06 Purchase +20,000 $57.03 $1,140,600 22,000 D: show line 1 in the form
Open-market purchases · 20,000 sh · avg $57.03 · $1,140,600
Loading xslF345X05/ownership.xml…